Indivior Inc. to pay $30 million to settle antitrust MDL with End Payors
LONDON, UK: Indivior Inc. has reached an agreement to resolve the claims brought by the end payor class of litigants (the End Payor Claimants) in the In re Suboxone Antitrust Litigation multi-district litigation (MDL). The agreement marks the resolution of…